Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series

Abstract

Hepatoid adenocarcinoma of the stomach (HAS) is an extremely rare and unique gastric malignancy. The present study aimed to examine the relevance of the clinicopathological characteristics of HAS with patient prognosis. We retrospectively reviewed clinical data of 34 HAS patients treated at our institution between January 2010 and December 2016, as well as 294 cases reported prior to 2017 in research databases. Among these patients, 45.6% (115/252) had lesions in the gastric antrum and 77.0% (235/305) were male. Elevated levels of serum alpha-fetoprotein (AFP) were detected in most patients (75/93, 80.6%). Vascular invasion (199/286, 69.6%), lymph node metastasis (222/283, 78.4%), and preoperative distant metastasis (121/328, 36.9%) were commonly observed. The 5-year disease-free survival (DFS) and disease-specific survival (DSS) were 20.7% and 29.2%, respectively. DFS and DSS of patients receiving neoadjuvant therapy were significantly higher than those of patients receiving postoperative adjuvant therapy [DFS: P<0.001, hazard ratio (HR)=–1.831, 95% confidence interval (CI): 0.060–0.429; DSS: P<0.001, HR=–2.185, 95% CI: 0.032–0.401]. In conclusion, HAS exhibits distinct clinicopathological characteristics and a strikingly worse prognosis when compared with common gastric cancer. Complete surgery, early pTNM stage, and adjuvant therapy may predict a more favorable prognosis. Neoadjuvant therapy is strongly recommended for patients with lymph node metastasis or/and preoperative distant metastasis.

Keywords

hepatoid adenocarcinoma / stomach / clinicopathological characteristics / adjuvant therapy / neoadjuvant therapy / prognosis

References

[1] ShenZ, LiuX, LuB, et al.. Hepatoid adenocarcinoma of the stomach: A case report of a rare type of gastric cancer. Oncol Lett, 2016, 11(2): 1077-1080

[2] XiaoC, WuF, JiangH, et al.. Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes. Oncol Lett, 2015, 10(3): 1605-1609

[3] GrossmanK, BeasleyMB, BramanSS. Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer. Respir Med, 2016, 119: 175-179

[4] OgbonnaOH, SakrutiS, SuliemanM, et al.. Hepatoid Adenocarcinoma of the Duodenum: An Unusual Location. Case Rep Oncol, 2016, 9(1): 182-187

[5] SuJS, ChenYT, WangRC, et al.. Clinicopathologicalal characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol, 2013, 19(3): 321-327

[6] IshikuraH, FukasawaY, OgasawaraK, et al.. An AFPproducing gastric carcinoma with features of hepatic differentiation. A case report. Cancer, 1985, 56: 840-848

[7] YangJ, WangR, ZhangW, et al.. Clinicopathologicalal and prognostic characteristics of hepatoid adenocarcinoma of the stomach. Gastroenterol Res Pract, 2014, 2014: 140587

[8] OsadaM, AishimaS, HirahashiM, et al.. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum Pathol, 2014, 45(6): 1243-1250

[9] LiuX, ShengW, WangY. An analysis of clinicopathologicalal features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer. J Surg Oncol, 2012, 106(3): 299-303

[10] BaekSK, HanSW, OhDY, et al.. Clinicopathological characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer. BMC Gastroenterol, 2011, 11: 56

[11] WanshingtonK. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol, 2010, 17: 3077-3079

[12] ChengCY, WuIC, ChenYT, et al.. A rare hepatoid adenocarcinoma from the gastric remnant. Kaohsiung J Med Sci, 2016, 32(9): 482-483

[13] BazeriesP, BarralM, LabrifeM, et al.. Hepatic metastases from gastric hepatoid adenocarcinoma: An unusual cause of capsular retraction of the liver. Diagn Interv Imaging., 2016, 97(9): 931-934

[14] GaetaR, UgoliniC, CastagnaM. Case Report of an Hepatoid Adenocarcinoma of the Stomach. Appl Immunohistochem Mol Morphol, 2016, 24(2): e6-e8

[15] LinYY, ChenCM, HuangYH, et al.. Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings. World J Gastroenterol, 2015, 21(48): 13524-13531

[16] SøreideJA, GreveOJ, GudlaugssonE, et al.. Hepatoid adenocarcinoma of the stomach—proper identification and treatment remain a challenge. Scand J Gastroenterol, 2016, 51(6): 646-653

[17] ZhouRU, CaiY, YangYI, et al.. Hepatoid adenocarcinoma of the stomach: A case report and review of the literature. Oncol Lett, 2015, 9(5): 2126-2128

[18] VelutG, MaryF, AflaloV, et al.. Magnetic resonance imaging diffusion-weighted imaging for diagnosis of a gastric hepatoid adenocarcinoma. Dig Liver Dis, 2015, 47(2): 174

[19] VelutG, MaryF, WindP, et al.. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma. Dig Liver Dis, 2014, 46(12): 1135-1136

[20] LinCY, YehHC, HsuCM, et al.. Clinicopathologial features of gastric hepatoid adenocarcinoma. Biomed J, 2015, 38(1): 65-69

[21] YeMF, TaoF, LiuF, et al.. Hepatoid adenocarcinoma of the stomach: a report of three cases. World J Gastroenterol, 2013, 19(27): 4437-44342

[22] JoJM, KimJW, HeoSH, et al.. Hepatic metastases from hepatoid adenocarcinoma of stomach mimicking hepatocellular carcinoma. Clin Mol Hepatol, 2012, 18(4): 420-423

[23] SuzukiA, KoideN, KitazawaM, et al.. Gastric composite tumor of alpha fetoprotein-producing carcinoma/hepatoid adenocarcinoma and endocrine carcinoma with reference to cellular phenotypes. Patholog Res Int, 2012, 2012: 201375

[24] YamanoiK, KondohY, FujiiT, et al.. Hepatoid adenocarcinoma of the stomach with multi-nucleated giant cell proliferation in a 100-year-old man. Pathol Int, 2010, 60(11): 750-754

[25] LuCC, De-ChuanC, LeeHS, et al.. Pure hepatoid adenocarcinoma of the stomach with spleen and lymphnode metastases. Am J Surg, 2010, 199(4): e42-e44

[26] VlachostergiosPJ, VoutsadakisIA, BarbanisS, et al.. AFP-producing hepatoid adenocarcinoma of the stomach: a case report. Cases J, 2009, 2: 9296

[27] LinCW, HsuCC, ChangHC, et al.. Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report. Cases J, 2009, 2: 6317

[28] LuoH, WangH, TanG, et al.. Hepatoid adenocarcinoma in stomach: a case report. Chi-Germ J Clinc Oncol, 2011, 10: 297

[29] Gálvez-MuñozE, Gallego-PlazasJ, Gonzalez-OrozcoV, et al.. Hepatoid adenocarcinoma of the stomach-a different histology for not so different gastric adenocarcinoma: a case report. Int Semin Surg Oncol, 2009, 6: 13

[30] ZhangS, WangM, XueYH, et al.. Cerebral metastasis from hepatoid adenocarcinoma of the stomach. World J Gastroenterol, 2007, 13(43): 5787-5793

[31] PlazaJA, VitellasK, FrankelWL. Hepatoid adenocarcinoma of the stomach. Ann Diagn Pathol., 2004, 8(3): 137-141

[32] TrompetasV, VarsamidakisN, FrangiaK, et al.. Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?. Eur J Gastroenterol Hepatol, 2003, 15(11): 1241-1244

[33] SohdaT, KusuharaH, EgashiraY, et al.. Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis. Clin J Gastroenterol, 2013, 6(6): 424-428

[34] SunX, LiY, DongM, et al.. Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings. Jpn J Radiol, 2014, 32(12): 721-724

[35] EmirS, KarakurtN, KarakuşE, et al.. Alpha-fetoproteinproducing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation. Turk J Pediatr, 2014, 56(1): 88-91

[36] MahajanV, GuptaN, GuptaS, et al.. Hepatoid adenocarcinoma of stomach: Case report of a rare histological variant. Indian J Pathol Microbiol, 2014, 57(1): 116-119

[37] LipiL, SachdevR, GautamD, et al.. Triple composite tumor of stomach: a rare combination of alpha fetoprotein positive hepatoid adenocarcinoma, tubular adenocarcinoma and large cell neuroendocrine carcinoma. Indian J Pathol Microbiol, 2014, 57(1): 98-100

[38] KumashiroY, YaoT, AishimaS, et al.. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol, 2007, 38(6): 857-863

[39] GaoYB, ZhangDF, JinXL, et al.. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma. J Dig Dis, 2007, 8(1): 23-28

[40] LeeMW, LeeJY, KimYJ, et al.. Gastric hepatoid adenocarcinoma: CT findings. Abdom Imaging, 2007, 32(3): 293-298

[41] TerraccianoLM, GlatzK, MhawechP, et al.. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol, 2003, 27(10): 1302-1312

[42] ZhangJF, ShiSS, ShaoYF, et al.. Clinicopathologicalal and prognostic features of hepatoid adenocarcinoma of the stomach. Chin Med J (Engl), 2011, 124(10): 1470-1476

[43] XieY, ZhaoZ, LiP, et al.. Hepatoid adenocarcinoma of the stomach is a special and easily misdiagnosed or missed diagnosed subtype of gastric cancer with poor prognosis but curative for patients of pN0/1: the experience of a single center. Int J Clin Exp Med, 2015, 8(5): 6762-6772

[44] RenA, CaiF, ShangYN, et al.. Gastric hepatoid adenocarcinoma: a computed tomography report of six cases. World J Gastroenterol, 2014, 20(40): 15001-15006

[45] WangW, ZhengC, FangC, et al.. Time trends of clinicopathological features and surgical treatment for gastric cancer: Results from 2 high-volume institutions in southern China. Surgery, 2015, 158(6): 1590-1597

[46] LiuX, ChengY, ShengW, et al.. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol, 2010, 34(10): 1465-1471